Harimata develops innovative, scientifically-validated technologies supporting early assessment and therapy of developmental disorders in children like autism, ADHD/ADD, intellectual disability. We specialise in combining experimental psychology with artificial intelligence. Our research and development projects are conducted in line with the highest scientific standards. Our product Play.Care is a tablet-based screening test supporting early detection of autism and other neurodevelopmental disorders in children aged 26. _______________________ This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No 756079.
Harimata develops innovative, scientifically-validated technologies supporting early assessment and therapy of developmental disorders in children like autism, ADHD/ADD, intellectual disability. We specialise in combining experimental psychology with artificial intelligence. Our research and development projects are conducted in line with the highest scientific standards. Our product Play.Care is a tablet-based screening test supporting early detection of autism and other neurodevelopmental disorders in children aged 26. _______________________ This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No 756079.
Company Information
- Industry
- Mental Health Care
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- Królewska 65a/1 Krakow
- City
- Krakow
- Region
- Lesser Poland Voivodeship
- Postal Code
- 30-081
- Country
- Poland